$2.5m Contract for clinical self-test development

Summary by AI BETAClose X

Abingdon Health plc has secured a significant contract valued at approximately US$2.5 million for the development and regulatory submission of a clinical self-test, with the majority of revenue expected in the financial year ending June 30, 2027. This 18-month project will involve Abingdon Health providing end-to-end project management and technical support across feasibility, design, development, verification, and validation phases, leveraging their expertise in lateral flow test development and regulatory pathways. The contract reinforces Abingdon Health's position as a leading provider of integrated CDMO/CRO services in the rapid diagnostic test market.

Disclaimer*

UK 100

Latest directors dealings